+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

Syringaresinol

BP4760
487-35-4
98%
Phytopurify
(-)-Syringaresinol may be a potential chemotherapeutic agent for the treatment of cancer; it against H/R-induced cardiomyocyte injury and death, the degradation of HIF-1α through activation of FOXO3 is a potential therapeutic strategy for ischemia-related diseases. Syringaresinol induces vasorelaxation by enhancing NO production in endothelial cells via two distinct mechanisms, phosphatidylinositol 3-kinase/Akt- and PLC/Ca(2+)/CaMKKβ-dependent eNOS phosphorylation and Ca(2+)-dependent eNOS dimerization. Syringaresinol is a lignan that is 7,9':7',9-diepoxylignane substituted by hydroxy groups at positions 4 and 4' and methoxy groups at positions 3, 3', 5 and 5' respectively. It has a role as a plant metabolite. It is a lignan, a polyphenol, an aromatic ether, a polyether and a furofuran.
Catalog No Package Original Price Price Inventory Quantity Operating
BP4760-10mg 10mg
BP4760-20mg 20mg
BP4760-100mg 100mg
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Related targets

NOS3 APP AMPK TNF NOS2 PPARG NFKB1 AKT1 IL1B
NOS3 BCL2 AMPK TNF NOS2 PPARG NFKB1 AKT1 IL1B KDR
TNF NOS2 NFKB1 IL1B TNF-α
APP BCL2 AMPK TNF NOS2 PPARG NFKB1 AKT1 IL1B

Syringaresinol Related Products

Product drug property prediction parameters

  • 95.8400

  • 2.5598

  • 2.5532

  • .0993

  • 7.3144

  • 4.2893

  • High

  • 89.5183

  • 3.7578

  • Yes

  • Yes

  • No

  • No

  • Yes

  • No

  • 0.0

  • Yes

  • No

  • No

  • No